A phase III trial of albumin-bound paclitaxel versus docetaxel as first-line therapy in patients with metastatic breast cancer.
Phase of Trial: Phase III
Latest Information Update: 01 Apr 2008
At a glance
- Drugs Docetaxel; Paclitaxel
- Indications Advanced breast cancer
- Focus Registrational; Therapeutic Use
- 01 Apr 2008 Agreement reached with FDA with regard to endpoints, under a Special Protocol Assessment.
- 01 Apr 2008 The trial is expected to be initiated in the second half of 2008.
- 13 Jun 2007 New trial record.